期刊文献+

P57免疫组化结合CEP17倍体分析在葡萄胎鉴别诊断中的作用 被引量:3

Application of P57 immunohistochemistry and CEP17 ploidy analysis in differential diagnosis of hydatidiform mole
下载PDF
导出
摘要 目的探讨P57免疫组化结合CEP17倍体分析在葡萄胎鉴别诊断中的意义。方法收集乌鲁木齐市妇幼保健院病理科45例完全性葡萄胎,25例部分性葡萄胎及25例水肿性流产标本,运用免疫组化进行P57检测和FISH技术进行CEP17的倍体检测。进一步分析P57免疫组化结合CEP17倍体分析在葡萄胎鉴别诊断中的意义。结果 P57蛋白在部分性葡萄胎和水肿性流产组织中主要分布在绒毛的细胞滋养细胞和间质细胞中,阳性表达比例分别为100%(25/25)和100%(25/25);但在绝大部分完全性葡萄胎中滋养细胞和间质细胞中P57表达缺失。P57在完全性葡萄胎中的阳性表达率为4.4%(2/45),与部分性葡萄胎(χ2=61.9,P<0.05)和水肿性流产比较(χ2=61.9,P<0.05),存在统计学差异。FISH分析结果显示:在水肿性流产中90.9%病例为CEP17二倍体(20/22);部分葡萄胎中87.0%病例为CEP17三倍体(20/23);在完全性葡萄胎中97.7%的病例为CEP17二倍体(42/43)。统计学分析结果显示:部分性葡萄胎三倍体的发生率明显高于水肿性流产(χ2=27.3,P<0.05)及完全性葡萄胎(χ2=49.6,P<0.05)。结论 P57免疫组化结合CEP17倍体分析对完全性葡萄胎,部分性葡萄胎和水肿性流产的鉴别诊断中具有重要的作用。 Objective To investigate the significance of P57 immunohistochemistry and CEP17 ploidy analysis in differential diagnosis of hydatidiform mole (HM). Methods The tissues amples, including 45 cases of complete hydatidiform mole ( CHM), 25 cases of partial hydatidiform mole (PHM) and 25 cases of hydropic abortuses (HA) , were collected from Urumqi Maternal and Child Health Hospital. The P57 expression and CEP17 ploidy analysis were analyzed using immunohistochemistry and fluorescence in situ hybridization FISH techniques, respectively. The significance of combining P57 immunohistochemistry and CEP17 ploidy analysis in the differential diagnosis of HM was further explored. Results P57 protein expression in PHM and HA was mainly in villous eytotrophoblast cells and stromal cells, and their rates of positive expression were 100% (25/25). But P57 expression was absent in cytotrophoblast cells and stromal cells in most CHM, and the positive expression rate was 4.4% (2/45) , which was statistically different from that in PHM and HA (χ2 = 61.9, both P 〈0.05). FISH analysis showed that CEP17 was diploid of CEP17 in 90.9% HA cases. In PHM cases, 87.0% (20/23) showed triploid of CEP17, and in CHM cases, 97.7% (42/43) showed diploid of CEP17. Statistical analysis showed that the incidence of triploid in PHM cases was significantly higher than in HA cases (χ2 = 27.3, P 〈 0.05 ) and CHM cases (χ2= 49.6, P 〈 0.05). Conclusion The combined analysis of P57 immunohistochemistry and CEP17 ploidy plays an important role in the differential diagnosis of CHM, PHM and HA.
出处 《中国妇幼健康研究》 2016年第11期1353-1356,共4页 Chinese Journal of Woman and Child Health Research
基金 乌鲁木齐市科学技术局基金资助项目(Y141310055)
关键词 葡萄胎 流产 免疫组织化学 CEP17倍体分析 hydatidiform mole (HM) abortion immnnohistoehemistry CEP17 ploidy analysis
  • 相关文献

参考文献4

二级参考文献75

  • 1黎华文,李英勇.葡萄胎恶变的研究进展[J].广东医学院学报,2005,23(6):673-675. 被引量:6
  • 2Kihara M,Matsui H,Seki K,et al.Genetic origin and imprinting in hydatidiform moles.Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.J Reprod Med,2005,50(5):307-312.
  • 3Kale A,S(o)ylemez F,Ensari A. Expressions of proliferation markers (Ki-67,proliferating cell nuclear antigen,and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.Am J Obstet Gynecol,2001,184(4):567-574.
  • 4McConnell TG,Murphy KM,Hafez M,et al. Diagnosis and subclassification of hydatidiform molesusing p57 immunohistochemistry and molecular genotyping:validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.Am J Surg Pathol,2009,33(6):805-817.
  • 5Bagshawe KD,Lawler SD,Paradinas FJ,et al. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.Lancet,1990,335(8697):1074-1076.
  • 6Crisp H,Burton JL,Stewart R,et al.Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57 KIP2 immunohistochemistry.Histopathology,2003,43 (4):363-373.
  • 7Matsuoka S,Thompson JS,Edwards MC,et al.Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor,p57KIP2,on chromosome 11p15.Proc Natl Acad Sci U S A,1996,93(7):3026-3030.
  • 8Chilosi M,Piazzola E,Lestani M,et al.Differential expression of P57,amaternally imprinted cdk inhibitor,in normal human placenta and ges-tational traphoblastic disease[J].Lab Invest, 1998,78:269-276.
  • 9Genest DR. Partial hydatidiform mole: clinicopathological features,differential diagnosis,ploidy and molecular studies, and gold stan-dards for diagnosis[J]. Int J Gynecol Pathol,2001,20(4):315-322.
  • 10Fukunaga M. Immunohistochemical characterization of p57(KIP2) ex-pression in early hydatidiform moles [J]. Hum pathol, 2002,33(12):1188-1192.

共引文献31

同被引文献38

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部